+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Molecular Diagnostics - Global Strategic Business Report

  • PDF Icon

    Report

  • 880 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 338507

Global Molecular Diagnostics Market to Reach $27 Billion by 2030

The global market for Molecular Diagnostics estimated at US$13.6 Billion in the year 2022, is projected to reach a revised size of US$27 Billion by 2030, growing at a CAGR of 9% over the analysis period 2022-2030. Reagents & Kits, one of the segments analyzed in the report, is projected to record 9.5% CAGR and reach US$16 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 8.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $5.8 Billion, While China is Forecast to Grow at 10.3% CAGR

The Molecular Diagnostics market in the U.S. is estimated at US$5.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 10.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.4% and 7.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Select Competitors (Total 84 Featured)

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Asuragen, Inc.
  • Analytik Jena AG
  • A. Menarini Diagnostics Srl
  • Abaxis, Inc.
  • Agena Bioscience, Inc.
  • Advanced Cell Diagnostics, Inc.
  • AutoGenomics, Inc.
  • Akonni Biosystems, Inc.
  • Berg LLC
  • Agendia, Inc.
  • BioAgilytix Labs

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

What`s New?

  • Special discussions on the global economic climate and market sentiment
  • Coverage on global competitiveness and key competitor percentage market shares
  • Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and trademarked research platform
  • Complimentary updates for one year
  • Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Frequently Asked Questions about the Molecular Diagnostics Market

What is the estimated value of the Molecular Diagnostics Market?

The Molecular Diagnostics Market was estimated to be valued at $13.6 Billion in 2022.

What is the growth rate of the Molecular Diagnostics Market?

The growth rate of the Molecular Diagnostics Market is 9.0%, with an estimated value of $27 Billion by 2030.

What is the forecasted size of the Molecular Diagnostics Market?

The Molecular Diagnostics Market is estimated to be worth $27 Billion by 2030.

Who are the key companies in the Molecular Diagnostics Market?

Key companies in the Molecular Diagnostics Market include Abbott Laboratories, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, Beckman Coulter, Inc., Asuragen, Inc., Analytik Jena AG, A. Menarini Diagnostics Srl, Abaxis, Inc., Agena Bioscience, Inc. and Advanced Cell Diagnostics, Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Impact of Covid-19 and a Looming Global Recession
  • Molecular Diagnostics Receive Healthy Booster from CoVid-19 Tests
  • Total Number of COVID-19 Tests Conducted in the Most Impacted Countries: As on August 27, 2020
  • Molecular Diagnostics Receive Healthy Booster from CoVid-19 Tests
  • RT-PCR Emerges as the Frontline Technology for Testing COVID-19
  • Performance Analysis of COVID-19 Tests
  • Need of the Hour: RT-PCR Shortages to be Tackled Effectively by Molecular Diagnostics Companies
  • Molecular Diagnostic Companies Re-strategize Logistics to Stay at the Top End of the Game
  • Select Tests Introduced for COVID-19
  • COVID-19 Plunges Fortunes of Non- COVID Diagnostics
  • Cancer Testing Dives During First Half of 2020
  • Myeloproliferative Neoplasm Tests Suffer the Brunt of CoVID-19 Curbs
  • Labs Embark New Journeys to Retain Overall Volumes
  • Influencer Market Insights
  • World Market Trajectories
  • Molecular Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
  • Molecular Diagnostics Competitor Market Share Scenario Worldwide (in %): 2020E
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • PCR (Technology) Global Competitor Market Share Positioning for 2020 & 2027
  • In-Situ Hybridization (Technology) Market Share Breakdown of Key Players: 2020 & 2027
  • Isothermal Amplification (Technology) Competitor Revenue Share (in %): 2020 & 2027
  • Sequencing (Technology) Market Share Shift by Company: 2020 & 2027
  • Chips & Microarrays (Technology) Global Competitor Market Share Positioning for 2020 & 2027
  • Reagents & Kits (Component) Market Share Breakdown of Key Players: 2020 & 2027
  • Instruments (Component) Competitor Revenue Share (in %): 2020 & 2027
  • Software & Service (Component) Market Share Shift by Company: 2020 & 2027
  • Molecular Diagnostics: An Introduction
  • Types of Molecular Diagnostics Tests
  • Market Outlook
  • Major Growth Drivers
  • Developing Countries Offer Strong Growth Prospects
  • PCR Technology Leads the MDx Market
  • Infectious Diseases: The Largest Application Market
  • Reagents and Kits Dominate the Molecular Diagnostics Market
  • Competition
  • Global Molecular Diagnostics Market by Leading Player (2019)
  • Global Molecular Diagnostics Market for Clostridium difficile by Leading Player: 2019
  • Pharmaceutical Firms Carve their Niche in Molecular Diagnostic Market
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Faster Screening Necessitates Point-of-Care Diagnostics for COVID-19
  • Molecular Diagnostics Market Eyes Transformational Impact of Proactive Diagnostics
  • Next-Generation Sequencing to Emerge as Novel Technique in Fight with COVID-19
  • Isothermal Amplification: An Alternative to RT-PCR for COVID-19 Testing
  • Technological Innovations Set to Drive Market Growth
  • New Product Developments
  • Digitalization Trends Benefit Growth
  • Growing Role of Molecular Diagnostics in Personalized Medicine
  • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
  • Companion Diagnostics Drive Personalized Medicine
  • Biomarkers as Companion Diagnostics
  • Oncology-Based Molecular Diagnostics Lead Growth
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
  • Number of New Cancer Cases and Deaths (in Million) by Region for 2018
  • New Applications Hold Promising Potential
  • Next-Generation Sequencing (NGS) Technologies Keep Up the Momentum
  • Rising Emphasis on Lab Automation to Augur Well for Market Growth
  • World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
  • Nanotechnology for Molecular Diagnostics
  • Growing Popularity of Chemo-Sensitivity Testing of CTCs
  • Genetic Disease Testing Offers Bright Prospects
  • Genetic Testing to Aid in Personalized Medicine
  • Pharmacogenomics Development Augurs Growth of Genetic Testing Market
  • Non-Invasive Prenatal Diagnostics - The Way Ahead
  • Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance
  • Growing Incidence of Infectious Diseases Spurs Opportunities
  • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
  • PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
  • Rising Incidence of Hospital Acquired Infections Propels Market Growth
  • Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
  • Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
  • Number of AIDS-Related Deaths (in Thousands) by Region for 2018
  • Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
  • Home HIV Testing Emerges as a Lucrative Option
  • Molecular Tests Gaining Prominence in GC/Chlamydia Testing Market
  • Molecular Diagnostics Opens New Avenues in Viral Hepatitis Testing
  • Hepatitis B prevalence Worldwide by Region
  • HPV Testing: A Fast Growing Segment in the Molecular Diagnostic Testing Market
  • HPV Associated Disorders Market by Indication: 2019
  • Cervical Cancer: Rising Incidence & Mortality Enhances Need for Testing
  • Number of New Cervix Uteri Cases in the World by Region (2018)
  • Molecular based Tests Ingrain Roots in Blood Donor Screening Segment
  • Rise in Healthcare Expenditure to Drive Growth
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Aging Population Drives Molecular Diagnostics Market
  • Elderly Healthcare Expenditure as a % of GDP
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 3: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 6: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 12: World 16-Year Perspective for Software & Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 14: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 15: World 16-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 17: World Historic Review for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 18: World 16-Year Perspective for In-Situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 21: World 16-Year Perspective for Isothermal Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 24: World 16-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 27: World 16-Year Perspective for Chips & Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 30: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 31: World Recent Past, Current & Future Analysis for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 32: World Historic Review for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 33: World 16-Year Perspective for Infectious Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 34: World Recent Past, Current & Future Analysis for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 35: World Historic Review for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 36: World 16-Year Perspective for Oncology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 37: World Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 38: World Historic Review for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 39: World 16-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 40: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 41: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 42: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 43: World Molecular Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Market Facts & Figures
  • US Molecular Diagnostics Market Share (in %) by Company: 2020 & 2027
  • PCR (Technology) Market Share Analysis (in %) of Leading Players in the US for 2020 & 2027
  • In-Situ Hybridization (Technology) Competitor Revenue Share (in %) in the US: 2020 & 2027
  • Isothermal Amplification (Technology) Market Share Breakdown (in %) of Major Players in the US: 2020 & 2027
  • Sequencing (Technology) Market in the US: Percentage Breakdown of Revenues by Company for 2020 & 2027
  • Chips & Microarrays (Technology) Competitor Market Share Breakdown (in %) in the US for 2020 & 2027
  • Reagents & Kits (Component) Market: Revenue Share Breakdown (in %) of Key Players in the US: 2020 & 2027
  • Instruments (Component) Market Share Analysis (in %) of Leading Players in the US for 2020 & 2027
  • Software & Service (Component) Competitor Revenue Share (in %) in the US: 2020 & 2027
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Market Analytics
  • Market Overview
  • Healthcare Spending as a % of GDP in the US: 2010-2020
  • US Emerges as a Major Market for COVID-19 Tests
  • FDA Plays Instrumental Role in Influx of New Tests
  • Select COVID-19 Test Kits with FDA Authorization
  • Cumulative Number of COVI-19 Tests Performed in the US (In ‘000): 31-Mar-30 July 2020
  • NIH Launches Initiative to Encourage Innovation
  • Infectious Disease Testing Contributes to High Growth
  • Ageing Demographics: Major Driving Factor
  • US Elderly Population: Expected Growth Rates Over the Years 2005-2025
  • Increasing Incidence of Chronic Diseases Drives Focus onto Molecular Diagnostics
  • Rising Incidence of Cancer: A Major Growth Driver
  • Leading Sites of New Cancer Cases in Males: 2020
  • Leading Sites of New Cancer Cases in Females: 2020
  • Molecular Diagnostics Tests Gain Share in STD Testing Domain
  • HPV Testing Market: A Review
  • Prevalence of HPV in the US by Age
  • US Personalized Medicine Market to Offer Significant Opportunities
  • Companion Diagnostics Market in the US
  • Burgeoning Potential for Genetic Testing
  • Paradigm Shift amongst Consumers Spurs DTC Genetic Testing Market
  • Market Analytics
  • CANADA
  • JAPAN
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Market Overview
  • Brief Note on COVID-19 Testing in Japan
  • Demographics Drive Market Growth
  • Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025
  • Market Analytics
  • CHINA
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Market Overview
  • COVID-19 Testing: An Overview
  • HPV Testing in China
  • Market Analytics
  • EUROPE
  • Market Facts & Figures
  • European Molecular Diagnostics Market: Competitor Market Share Scenario (in %) for 2020 & 2027
  • PCR (Technology) Market Share (in %) by Company in Europe: 2020 & 2027
  • In-Situ Hybridization (Technology) Market Share (in %) of Major Players in Europe: 2020 & 2027
  • Isothermal Amplification (Technology) Competitor Market Share Analysis (in %) in Europe: 2020 & 2027
  • Sequencing (Technology) Market in Europe: Competitor Revenue Share Shift (in %) for 2020 & 2027
  • Chips & Microarrays (Technology) Competitor Market Share (in %) Positioning in Europe for 2020 & 2027
  • Reagents & Kits (Component) Key Player Market Share Breakdown (in %) in Europe: 2020 & 2027
  • Instruments (Component) Market Share (in %) by Company in Europe: 2020 & 2027
  • Software & Service (Component) Market Share (in %) of Major Players in Europe: 2020 & 2027
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Market Overview
  • COVID-19 Testing Drives Revenue Growth
  • Covid-19 Testing in the UK
  • Aging Population: A Prime Growth Driver
  • Automated Systems Gain Preeminence
  • Oncology-based Molecular Diagnostics Holds Immense Potential
  • Number of New Cancer Cases in Europe: 2012, 2018, and 2025
  • Distribution of New Cancer Cases by Type in Europe: 2018
  • HPV Testing in Europe: An Overview
  • Market Analytics
  • Market Analytics
  • FRANCE
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • GERMANY
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • ITALY
  • UNITED KINGDOM
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Market Overview
  • Healthcare Spending in Asia-Pacific: On the Rise
  • Market Analytics
  • AUSTRALIA
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
  • INDIA
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
  • Market Overview
  • Laboratories Pick up on Automation
  • HPV Testing Market: An Overview
  • HPV in India: Breakdown of Type-Distribution and HPV Prevalence
  • Market Analytics
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Asuragen, Inc.
  • Analytik Jena AG
  • A. Menarini Diagnostics Srl
  • Abaxis, Inc.
  • Agena Bioscience, Inc.
  • Advanced Cell Diagnostics, Inc.
  • AutoGenomics, Inc.
  • Akonni Biosystems, Inc.
  • Berg LLC
  • Agendia, Inc.
  • BioAgilytix Labs